Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Wood David S. | Chief Financial Officer | 6 | $21.6K | $0 | 2025-10-09 |
| Thorell Marella | Director | 5 | $0 | $0 | 2025-10-09 |
| Requadt Scott | Director | 7 | $0 | $0 | 2025-10-09 |
| Martin John Alexander | Director | 5 | $0 | $0 | 2025-10-09 |
| Parkinson David Ross | President and CEO | 8 | $94.7K | $0 | 2025-10-09 |
| Glickman Richard M | Director | 7 | $0 | $0 | 2025-10-09 |
| BERGER FRANKLIN M | Director | 26 | $2.09M | $729.1K | 2025-10-09 |
| BVF INC/IL | 10% Owner | 12 | $0 | $293 | 2025-10-09 |
| BB BIOTECH AG | 10% Owner | 6 | $948.0K | $12.17M | 2024-11-01 |
| Virsik Peter | Chief Operating Officer | 20 | $0 | $819.3K | 2024-10-07 |
| Kantoff Philip W. | Director | 1 | $0 | $0 | 2024-03-25 |
| Merendino Lauren | Director | 1 | $0 | $0 | 2024-03-25 |
| Cesano Alessandra | Chief Medical Officer | 3 | $0 | $0 | 2024-03-25 |
| Sollis Gary | Director | 4 | $0 | $0 | 2024-03-25 |
| ZWEIFACH SANFORD S | Director | 4 | $0 | $0 | 2024-03-25 |
| BIOTECH GROWTH N V | 10% Owner | 5 | $12.17M | $0 | 2022-10-27 |
| Brettman Ari David | Director | 2 | $0 | $0 | 2020-12-11 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| BVF INC/IL | 10% Owner | U Tender | 2025-10-09 | 2025-10-14 | 4,726,743 | — | $0 | 0 | SEC↗ |
| BVF INC/IL | 10% Owner | U Tender | 2025-10-09 | 2025-10-14 | 560,797 | — | $0 | 0 | SEC↗ |
| BVF INC/IL | 10% Owner | U Tender | 2025-10-09 | 2025-10-14 | 6,194,145 | — | $0 | 0 | SEC↗ |
| Thorell Marella | Director | D To issuer | 2025-10-09 | 2025-10-15 | 2,881 | — | $0 | 0 | SEC↗ |
| Martin John Alexander | Director | D To issuer | 2025-10-09 | 2025-10-15 | 14,299 | — | $0 | 0 | SEC↗ |
| Requadt Scott | Director | D To issuer | 2025-10-09 | 2025-10-15 | 30,002 | — | $0 | 0 | SEC↗ |
| Glickman Richard M | Director | D To issuer | 2025-10-09 | 2025-10-15 | 43,240 | — | $0 | 0 | SEC↗ |
| BERGER FRANKLIN M | Director | D To issuer | 2025-10-09 | 2025-10-15 | 784,404 | — | $0 | 0 | SEC↗ |
| Wood David S. | Chief Financial Officer | D To issuer | 2025-10-09 | 2025-10-15 | 33,343 | — | $0 | 0 | SEC↗ |
| Parkinson David Ross | President and CEO | D To issuer | 2025-10-09 | 2025-10-15 | 65,675 | — | $0 | 0 | SEC↗ |
| BVF INC/IL | 10% Owner | X Exercise deriv | 2025-08-05 | 2025-08-07 | 1,481,634 | — | $0 | 0 | SEC↗ |
| BVF INC/IL | 10% Owner | X Exercise deriv | 2025-08-05 | 2025-08-07 | 1,235,030 | — | $0 | 0 | SEC↗ |
| BVF INC/IL | 10% Owner | X Exercise deriv | 2025-08-05 | 2025-08-07 | 203,336 | — | $0 | 0 | SEC↗ |
| BVF INC/IL | 10% Owner | X Exercise | 2025-08-05 | 2025-08-07 | 203,336 | — | $0 | 560,808 | SEC↗ |
| BVF INC/IL | 10% Owner | X Exercise | 2025-08-05 | 2025-08-07 | 1,235,030 | — | $0 | 4,726,809 | SEC↗ |
| BVF INC/IL | 10% Owner | X Exercise | 2025-08-05 | 2025-08-07 | 1,481,634 | — | $0 | 6,194,224 | SEC↗ |
| BVF INC/IL | 10% Owner | S Sale | 2025-08-05 | 2025-08-07 | 66 | $1.88 | $124 | 4,726,743 | SEC↗ |
| BVF INC/IL | 10% Owner | S Sale | 2025-08-05 | 2025-08-07 | 11 | $1.88 | $21 | 560,797 | SEC↗ |
| BVF INC/IL | 10% Owner | S Sale | 2025-08-05 | 2025-08-07 | 79 | $1.88 | $149 | 6,194,145 | SEC↗ |
| BB BIOTECH AG | 10% Owner | S Sale | 2024-11-01 | 2024-11-05 | 2,000,000 | $1.53 | $3.06M | 5,879,583 | SEC↗ |
| BB BIOTECH AG | 10% Owner | S Sale | 2024-11-01 | 2024-11-05 | 1,879,583 | $1.51 | $2.84M | 0 | SEC↗ |
| BB BIOTECH AG | 10% Owner | S Sale | 2024-11-01 | 2024-11-05 | 2,000,000 | $1.53 | $3.06M | 1,879,583 | SEC↗ |
| BB BIOTECH AG | 10% Owner | S Sale | 2024-11-01 | 2024-11-05 | 2,000,000 | $1.53 | $3.06M | 3,879,583 | SEC↗ |
| Virsik Peter | Chief Operating Officer | S Sale | 2024-10-07 | 2024-10-07 | 694 | $6.03 | $4.2K | 7,776 | SEC↗ |
| Virsik Peter | Chief Operating Officer | S Sale | 2024-09-09 | 2024-09-09 | 694 | $6.00 | $4.2K | 8,470 | SEC↗ |
| Virsik Peter | Chief Operating Officer | S Sale | 2024-09-03 | 2024-09-03 | 2,082 | $6.03 | $12.6K | 9,164 | SEC↗ |
| Virsik Peter | Chief Operating Officer | S Sale | 2024-05-06 | 2024-05-06 | 694 | $6.95 | $4.8K | 11,246 | SEC↗ |
| Glickman Richard M | Director | M Exercise deriv | 2024-04-24 | 2024-04-25 | 3,750 | — | $0 | 0 | SEC↗ |
| Glickman Richard M | Director | M Exercise | 2024-04-24 | 2024-04-25 | 3,750 | $4.90 | $18.4K | 43,240 | SEC↗ |
| Virsik Peter | Chief Operating Officer | S Sale | 2024-04-05 | 2024-04-05 | 694 | $7.94 | $5.5K | 11,940 | SEC↗ |
| Cesano Alessandra | Chief Medical Officer | A Award deriv | 2024-03-25 | 2024-03-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Parkinson David Ross | Chief Executive Officer | A Award deriv | 2024-03-25 | 2024-03-28 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Virsik Peter | Chief Operating Officer | A Award deriv | 2024-03-25 | 2024-03-28 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Wood David S. | Chief Financial Officer | A Award deriv | 2024-03-25 | 2024-03-28 | 110,000 | — | $0 | 110,000 | SEC↗ |
| BERGER FRANKLIN M | Director | A Award deriv | 2024-03-25 | 2024-03-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2024-03-25 | 2024-03-28 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Kantoff Philip W. | Director | A Award deriv | 2024-03-25 | 2024-03-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Martin John Alexander | Director | A Award deriv | 2024-03-25 | 2024-03-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Merendino Lauren | Director | A Award deriv | 2024-03-25 | 2024-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Requadt Scott | Director | A Award deriv | 2024-03-25 | 2024-03-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Sollis Gary | Director | A Award deriv | 2024-03-25 | 2024-03-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Thorell Marella | Director | A Award deriv | 2024-03-25 | 2024-03-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ZWEIFACH SANFORD S | Director | A Award deriv | 2024-03-25 | 2024-03-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Virsik Peter | Chief Operating Officer | S Sale | 2024-03-05 | 2024-03-05 | 694 | $8.98 | $6.2K | 12,634 | SEC↗ |
| Virsik Peter | Chief Operating Officer | M Exercise deriv | 2024-02-06 | 2024-02-07 | 72,782 | — | $0 | 895,000 | SEC↗ |
| Virsik Peter | Chief Operating Officer | S Sale | 2024-02-06 | 2024-02-07 | 72,782 | $10.29 | $748.9K | 13,328 | SEC↗ |
| Virsik Peter | Chief Operating Officer | M Exercise | 2024-02-06 | 2024-02-07 | 72,782 | $3.23 | $235.1K | 86,110 | SEC↗ |
| Virsik Peter | Chief Operating Officer | M Exercise deriv | 2024-02-05 | 2024-02-06 | 500 | — | $0 | 967,782 | SEC↗ |
| Virsik Peter | Chief Operating Officer | S Sale | 2024-02-05 | 2024-02-06 | 694 | $9.25 | $6.4K | 13,328 | SEC↗ |
| Virsik Peter | Chief Operating Officer | M Exercise | 2024-02-05 | 2024-02-06 | 500 | $3.23 | $1.6K | 13,828 | SEC↗ |
| Virsik Peter | Chief Operating Officer | S Sale | 2024-02-05 | 2024-02-06 | 500 | $10.04 | $5.0K | 13,328 | SEC↗ |
| Virsik Peter | Chief Operating Officer | M Exercise deriv | 2024-01-16 | 2024-01-17 | 1,718 | — | $0 | 968,282 | SEC↗ |
| Virsik Peter | Chief Operating Officer | S Sale | 2024-01-16 | 2024-01-17 | 1,718 | $10.01 | $17.2K | 14,022 | SEC↗ |
| Virsik Peter | Chief Operating Officer | M Exercise | 2024-01-16 | 2024-01-17 | 1,718 | $3.23 | $5.5K | 15,740 | SEC↗ |
| Virsik Peter | Chief Operating Officer | S Sale | 2024-01-05 | 2024-01-08 | 699 | $6.11 | $4.3K | 14,022 | SEC↗ |
| Parkinson David Ross | Chief Executive Officer | P Buy | 2023-12-14 | 2023-12-18 | 9,223 | $2.30 | $21.2K | 65,675 | SEC↗ |
| BERGER FRANKLIN M | Director | P Buy | 2023-11-21 | 2023-11-22 | 23,259 | $5.73 | $133.3K | 784,404 | SEC↗ |
| Requadt Scott | Director | J Other | 2023-11-06 | 2024-01-16 | 12,500 | — | $0 | 30,002 | SEC↗ |
| BERGER FRANKLIN M | Director | P Buy | 2023-11-03 | 2023-11-16 | 16,471 | $5.99 | $98.7K | 760,875 | SEC↗ |
| BERGER FRANKLIN M | Director | P Buy | 2023-11-02 | 2023-11-16 | 60,000 | $5.35 | $321.0K | 744,404 | SEC↗ |
| Requadt Scott | Director | J Other | 2023-10-30 | 2024-01-16 | 17,502 | — | $0 | 42,502 | SEC↗ |
| Wood David S. | Chief Financial Officer | A Award deriv | 2023-10-24 | 2023-11-24 | 3,750 | — | $0 | 3,750 | SEC↗ |
| Wood David S. | Chief Financial Officer | P Buy | 2022-12-30 | 2023-01-05 | 8,302 | $2.60 | $21.6K | 33,343 | SEC↗ |
| Parkinson David Ross | Chief Executive Officer | P Buy | 2022-12-30 | 2023-01-05 | 3,067 | $2.60 | $8.0K | 56,542 | SEC↗ |
| Parkinson David Ross | Chief Executive Officer | P Buy | 2022-12-22 | 2023-01-05 | 21,367 | $2.39 | $51.1K | 53,475 | SEC↗ |
| BERGER FRANKLIN M | Director | S Sale | 2022-12-21 | 2023-01-05 | 34,334 | $2.42 | $83.1K | 684,404 | SEC↗ |
| BERGER FRANKLIN M | Director | S Sale | 2022-12-21 | 2023-01-05 | 37,889 | $2.41 | $91.3K | 718,738 | SEC↗ |
| BERGER FRANKLIN M | Director | S Sale | 2022-12-20 | 2023-01-05 | 43,617 | $2.53 | $110.4K | 756,627 | SEC↗ |
| BERGER FRANKLIN M | Director | S Sale | 2022-12-16 | 2023-01-05 | 50,000 | $2.67 | $133.5K | 800,244 | SEC↗ |
| BERGER FRANKLIN M | Director | S Sale | 2022-12-15 | 2023-01-05 | 32,000 | $2.90 | $92.8K | 900,244 | SEC↗ |
| BERGER FRANKLIN M | Director | S Sale | 2022-12-15 | 2023-01-05 | 50,000 | $2.86 | $143.0K | 850,244 | SEC↗ |
| BERGER FRANKLIN M | Director | S Sale | 2022-12-14 | 2023-01-05 | 25,000 | $3.00 | $75.0K | 932,244 | SEC↗ |
| BIOTECH GROWTH N V | 10% Owner | P Buy | 2022-10-27 | 2022-10-28 | 500,000 | $4.50 | $2.25M | 7,879,583 | SEC↗ |
| BIOTECH GROWTH N V | 10% Owner | P Buy | 2022-10-26 | 2022-10-28 | 1,500,000 | $3.98 | $5.97M | 7,379,583 | SEC↗ |
| BB BIOTECH AG | 10% Owner | P Buy | 2022-07-18 | 2022-07-20 | 300,000 | $3.16 | $948.0K | 5,879,583 | SEC↗ |
| BIOTECH GROWTH N V | 10% Owner | P Buy | 2022-07-15 | 2022-07-18 | 241,665 | $3.13 | $756.4K | 5,579,583 | SEC↗ |
| BIOTECH GROWTH N V | 10% Owner | P Buy | 2022-07-14 | 2022-07-18 | 347,204 | $2.79 | $968.7K | 5,337,918 | SEC↗ |
| Parkinson David Ross | Chief Executive Officer | P Buy | 2022-06-30 | 2022-07-05 | 4,887 | $2.96 | $14.5K | 32,108 | SEC↗ |
| BERGER FRANKLIN M | Director | A Award deriv | 2022-06-29 | 2022-11-01 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Cesano Alessandra | Chief Medical Officer | A Award deriv | 2022-06-29 | 2022-11-01 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2022-06-29 | 2022-11-01 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Martin John Alexander | Director | A Award deriv | 2022-06-29 | 2022-11-01 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Parkinson David Ross | Chief Executive Officer | A Award deriv | 2022-06-29 | 2022-11-01 | 222,500 | — | $0 | 222,500 | SEC↗ |
| Requadt Scott | Director | A Award deriv | 2022-06-29 | 2022-11-01 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Sollis Gary | Director | A Award deriv | 2022-06-29 | 2022-11-01 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Thorell Marella | Director | A Award deriv | 2022-06-29 | 2022-11-01 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Virsik Peter | Chief Operating Officer | A Award deriv | 2022-06-29 | 2022-11-01 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Wood David S. | Chief Financial Officer | A Award deriv | 2022-06-29 | 2022-11-01 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ZWEIFACH SANFORD S | Director | A Award deriv | 2022-06-29 | 2022-11-01 | 22,500 | — | $0 | 22,500 | SEC↗ |
| BB BIOTECH AG | 10% Owner | S Sale | 2022-04-27 | 2022-04-28 | 25,100 | $5.85 | $146.8K | 4,990,714 | SEC↗ |
| BIOTECH GROWTH N V | 10% Owner | P Buy | 2021-08-18 | 2021-08-20 | 250,000 | $8.88 | $2.22M | 5,015,814 | SEC↗ |
| BERGER FRANKLIN M | Director | P Buy | 2021-02-22 | 2021-03-04 | 57,000 | $27.00 | $1.54M | 957,244 | SEC↗ |
| BERGER FRANKLIN M | Director | A Award deriv | 2020-12-11 | 2021-01-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Brettman Ari David | Director | A Award deriv | 2020-12-11 | 2021-01-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Cesano Alessandra | Chief Medical Officer | A Award deriv | 2020-12-11 | 2021-01-11 | 57,500 | — | $0 | 57,500 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2020-12-11 | 2021-01-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Martin John Alexander | Director | A Award deriv | 2020-12-11 | 2021-01-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Parkinson David Ross | Chief Executive Officer | A Award deriv | 2020-12-11 | 2021-01-11 | 266,948 | — | $0 | 266,948 | SEC↗ |
| Requadt Scott | Director | A Award deriv | 2020-12-11 | 2021-01-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Sollis Gary | Director | A Award deriv | 2020-12-11 | 2021-01-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Thorell Marella | Director | A Award deriv | 2020-12-11 | 2021-01-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Virsik Peter | Chief Operating Officer | A Award deriv | 2020-12-11 | 2021-01-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Wood David S. | Chief Financial Officer | A Award deriv | 2020-12-11 | 2021-01-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ZWEIFACH SANFORD S | Director | A Award deriv | 2020-12-11 | 2021-01-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| BERGER FRANKLIN M | Director | A Award deriv | 2020-12-11 | 2021-01-26 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Brettman Ari David | Director | A Award deriv | 2020-12-11 | 2021-01-26 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Glickman Richard M | Director | A Award deriv | 2020-12-11 | 2021-01-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Martin John Alexander | Director | A Award deriv | 2020-12-11 | 2021-01-26 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Requadt Scott | Director | A Award deriv | 2020-12-11 | 2021-01-26 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Sollis Gary | Director | A Award deriv | 2020-12-11 | 2021-01-26 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Thorell Marella | Director | A Award deriv | 2020-12-11 | 2021-01-26 | 16,500 | — | $0 | 16,500 | SEC↗ |
| ZWEIFACH SANFORD S | Director | A Award deriv | 2020-12-11 | 2021-01-26 | 16,500 | — | $0 | 16,500 | SEC↗ |
| BERGER FRANKLIN M | Director | M Exercise deriv | 2020-12-03 | 2021-01-11 | 6,534 | — | $0 | 2,966 | SEC↗ |
| BERGER FRANKLIN M | Director | M Exercise deriv | 2020-12-03 | 2021-01-11 | 1,716 | — | $0 | 784 | SEC↗ |
| BERGER FRANKLIN M | Director | M Exercise deriv | 2020-12-03 | 2021-01-11 | 25,000 | — | $0 | 0 | SEC↗ |
| BERGER FRANKLIN M | Director | M Exercise deriv | 2020-12-03 | 2021-01-11 | 6,773 | — | $0 | 18,227 | SEC↗ |
| BERGER FRANKLIN M | Director | M Exercise deriv | 2020-12-03 | 2021-01-11 | 2,184 | — | $0 | 2,816 | SEC↗ |
| BERGER FRANKLIN M | Director | M Exercise | 2020-12-03 | 2021-01-11 | 2,184 | $3.81 | $8.3K | 868,471 | SEC↗ |
| BERGER FRANKLIN M | Director | M Exercise | 2020-12-03 | 2021-01-11 | 25,000 | $3.23 | $80.8K | 893,471 | SEC↗ |
| BERGER FRANKLIN M | Director | M Exercise | 2020-12-03 | 2021-01-11 | 6,773 | $4.67 | $31.6K | 900,244 | SEC↗ |
| BERGER FRANKLIN M | Director | M Exercise | 2020-12-03 | 2021-01-11 | 6,534 | $4.00 | $26.1K | 866,287 | SEC↗ |
| BERGER FRANKLIN M | Director | M Exercise | 2020-12-03 | 2021-01-11 | 1,716 | $4.00 | $6.9K | 859,753 | SEC↗ |